Acasti voluntarily delists from TSX Venture; confirms no SVB/Silvergate exposure

Grace Therapeutics, Inc.

Voluntary delisting from TSXV effective March 27, 2023; Nasdaq listing under ACST unaffected.
Company cites low TSXV volume and high dual-listing costs; expects central Nasdaq marketplace to aid liquidity.
Confirms no exposure to Silicon Valley Bank or Silvergate Bank; no deposits held at those institutions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.